Vitaspring Biomedical Co. Ltd.
VSBC· OTC
Filed Jun 4, 2018 · 10-Q · 35 days after period end · 0001697884-18-000011
| Metric | Q1 2018 | Q1 2017 |
|---|---|---|
| Revenue | $12.45K | $6.12K |
| Net Income | $4.98K | -$1.10K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR
ended Apr 30, 2018 · filed Jun 4, 2018 · 35 d after period end